BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7759154)

  • 21. Reproductive factors and cancers of the breast and genital organs--are the different cancer sites similarly affected?
    Kvåle G; Heuch I; Nilssen S
    Cancer Detect Prev; 1991; 15(5):369-77. PubMed ID: 1751947
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic impact of parity in 493 uterine sarcoma patients.
    Albrektsen G; Heuch I; Wik E; Salvesen HB
    Int J Gynecol Cancer; 2009 Aug; 19(6):1062-7. PubMed ID: 19820369
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Incidence and survival trends of uncommon corpus uteri malignancies in the Netherlands, 1989-2008.
    Boll D; Verhoeven RH; van der Aa MA; Pauwels P; Karim-Kos HE; Coebergh JW; van Doorn HC
    Int J Gynecol Cancer; 2012 May; 22(4):599-606. PubMed ID: 22398706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A prospective study of reproductive factors and breast cancer. II. Age at first and last birth.
    Kvåle G; Heuch I
    Am J Epidemiol; 1987 Nov; 126(5):842-50. PubMed ID: 3661532
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pregnancy duration and endometrial cancer risk: nationwide cohort study.
    Husby A; Wohlfahrt J; Melbye M
    BMJ; 2019 Aug; 366():l4693. PubMed ID: 31412996
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reproductive factors and risk of cancer of the uterine corpus: a prospective study.
    Kvåle G; Heuch I; Ursin G
    Cancer Res; 1988 Nov; 48(21):6217-21. PubMed ID: 3167867
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Age at last birth in relation to risk of endometrial cancer: pooled analysis in the epidemiology of endometrial cancer consortium.
    Setiawan VW; Pike MC; Karageorgi S; Deming SL; Anderson K; Bernstein L; Brinton LA; Cai H; Cerhan JR; Cozen W; Chen C; Doherty J; Freudenheim JL; Goodman MT; Hankinson SE; Lacey JV; Liang X; Lissowska J; Lu L; Lurie G; Mack T; Matsuno RK; McCann S; Moysich KB; Olson SH; Rastogi R; Rebbeck TR; Risch H; Robien K; Schairer C; Shu XO; Spurdle AB; Strom BL; Thompson PJ; Ursin G; Webb PM; Weiss NS; Wentzensen N; Xiang YB; Yang HP; Yu H; Horn-Ross PL; De Vivo I;
    Am J Epidemiol; 2012 Aug; 176(4):269-78. PubMed ID: 22831825
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Menstrual and reproductive factors in relation to risk of endometrial cancer in Chinese women.
    Wernli KJ; Ray RM; Gao DL; De Roos AJ; Checkoway H; Thomas DB
    Cancer Causes Control; 2006 Sep; 17(7):949-55. PubMed ID: 16841262
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of pregnancy as a risk factor for breast cancer in BRCA1/BRCA2 mutation carriers.
    Cullinane CA; Lubinski J; Neuhausen SL; Ghadirian P; Lynch HT; Isaacs C; Weber B; Moller P; Offit K; Kim-Sing C; Friedman E; Randall S; Pasini B; Ainsworth P; Gershoni-Baruch R; Foulkes WD; Klijn J; Tung N; Rennert G; Olopade O; Couch F; Wagner T; Olsson H; Sun P; Weitzel JN; Narod SA
    Int J Cancer; 2005 Dec; 117(6):988-91. PubMed ID: 15986445
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Poorer survival of nulliparous women with endometrial carcinoma.
    Salvesen HB; Akslen LA; Albrektsen G; Iversen OE
    Cancer; 1998 Apr; 82(7):1328-33. PubMed ID: 9529025
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Associations between pregnancy-related factors and birth characteristics with risk of rare uterine cancer subtypes: a Nordic population-based case-control study.
    Abril J; Trabert B; Troisi R; Grotmol T; Ekbom A; Engeland A; Gissler M; Glimelius I; Madanat-Harjuoja L; Gulbech Ording A; Sørensen HT; Tretli S; Bjørge T
    Cancer Causes Control; 2024 May; 35(5):741-747. PubMed ID: 38129544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Association of time since last birth, age at first birth and parity with breast cancer survival among parous women: a register-based study from Norway.
    Alsaker MD; Opdahl S; Romundstad PR; Vatten LJ
    Int J Cancer; 2013 Jan; 132(1):174-81. PubMed ID: 22511284
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Female Hormonal Factors and the Risk of Endometrial Cancer in Lynch Syndrome.
    Dashti SG; Chau R; Ouakrim DA; Buchanan DD; Clendenning M; Young JP; Winship IM; Arnold J; Ahnen DJ; Haile RW; Casey G; Gallinger S; Thibodeau SN; Lindor NM; Le Marchand L; Newcomb PA; Potter JD; Baron JA; Hopper JL; Jenkins MA; Win AK
    JAMA; 2015 Jul; 314(1):61-71. PubMed ID: 26151267
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of reproductive factors on the risk of endometrial cancer.
    Parazzini F; Negri E; La Vecchia C; Benzi G; Chiaffarino F; Polatti A; Francheschi S
    Int J Cancer; 1998 Jun; 76(6):784-6. PubMed ID: 9626340
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Parity in relation to mortality and cancer incidence: a prospective study of Norwegian women.
    Kvåle G; Heuch I; Nilssen S
    Int J Epidemiol; 1994 Aug; 23(4):691-9. PubMed ID: 8002181
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Family history of breast cancer and short-term effects of childbirths on breast cancer risk.
    Albrektsen G; Heuch I; Thoresen S; Kvåle G
    Int J Cancer; 2006 Sep; 119(6):1468-74. PubMed ID: 16642468
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hormone contraception before the first birth and endometrial cancer risk.
    Cook LS; Dong Y; Round P; Huang X; Magliocco AM; Friedenreich CM
    Cancer Epidemiol Biomarkers Prev; 2014 Feb; 23(2):356-61. PubMed ID: 24326627
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical stage of breast cancer by parity, age at birth, and time since birth: a progressive effect of pregnancy hormones?
    Albrektsen G; Heuch I; Thoresen S; Kvåle G
    Cancer Epidemiol Biomarkers Prev; 2006 Jan; 15(1):65-9. PubMed ID: 16434588
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pregnancy outcomes and risk of endometrial cancer: A pooled analysis of individual participant data in the Epidemiology of Endometrial Cancer Consortium.
    Jordan SJ; Na R; Weiderpass E; Adami HO; Anderson KE; van den Brandt PA; Brinton LA; Chen C; Cook LS; Doherty JA; Du M; Friedenreich CM; Gierach GL; Goodman MT; Krogh V; Levi F; Lu L; Miller AB; McCann SE; Moysich KB; Negri E; Olson SH; Petruzella S; Palmer JR; Parazzini F; Pike MC; Prizment AE; Rebbeck TR; Reynolds P; Ricceri F; Risch HA; Rohan TE; Sacerdote C; Schouten LJ; Serraino D; Setiawan VW; Shu XO; Sponholtz TR; Spurdle AB; Stolzenberg-Solomon RZ; Trabert B; Wentzensen N; Wilkens LR; Wise LA; Yu H; La Vecchia C; De Vivo I; Xu W; Zeleniuch-Jacquotte A; Webb PM
    Int J Cancer; 2021 May; 148(9):2068-2078. PubMed ID: 33105052
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Levonorgestrel-releasing intrauterine system use is associated with a decreased risk of ovarian and endometrial cancer, without increased risk of breast cancer. Results from the NOWAC Study.
    Jareid M; Thalabard JC; Aarflot M; Bøvelstad HM; Lund E; Braaten T
    Gynecol Oncol; 2018 Apr; 149(1):127-132. PubMed ID: 29482839
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.